Literature DB >> 22230167

Helicobacter pylori infection is strongly associated with gastric and duodenal ulcers in a large prospective study.

Ben Schöttker1, Mariam A Adamu, Melanie N Weck, Hermann Brenner.   

Abstract

BACKGROUND & AIMS: Infection with Helicobacter pylori (H pylori) is a risk factor for peptic ulcer disease (PUD), but there are limited longitudinal data on the associations between infection and incident gastric or duodenal ulcers.
METHODS: Information on potential risk factors, lifetime history of PUD, and serologic measurements of H pylori infection were obtained from a German cohort of 9953 adults, 50 to 74 years old at baseline (2000-2002). The incidence of ulcers was determined by questionnaires sent to study participants and general practitioners 2 and 5 years later, and was validated by medical records.
RESULTS: A lifetime history of PUD was reported by 1030 participants, and during the follow-up period 48 had a first gastric and 22 had a first duodenal ulcer. Infection with H pylori strains that express cytotoxin-associated gene A (cagA) was significantly associated with a lifetime history of PUD (odds ratio, 1.75; 95% confidence interval [CI], 1.50-2.04). Based on longitudinal analyses with physician-validated end points, the adjusted hazard ratios for incident gastric and duodenal ulcer disease were 2.9 (95% CI, 1.5-5.5) and 18.4 (95% CI, 4.2-79.9), respectively, among patients infected with cagA-positive strains of H pylori.
CONCLUSIONS: In cross-sectional analysis, infection with cagA-positive strains of H pylori was associated with a 1.75-fold increased risk of peptic ulcer disease. Longitudinal analyses revealed an 18.4- and 2.9-fold increased risk for duodenal ulcer and gastric ulcer, respectively. The proportion of PUD that is attributable to H pylori infection might be larger than previously believed.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22230167     DOI: 10.1016/j.cgh.2011.12.036

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  14 in total

Review 1.  Association of Helicobacter pylori babA2 with peptic ulcer disease and gastric cancer.

Authors:  Mo-Ye Chen; Cai-Yun He; Xue Meng; Yuan Yuan
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

2.  Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer.

Authors:  Kento Takatori; Kazuki Terashima; Rihito Yoshida; Aya Horai; Shinya Satake; Takayuki Ose; Naoto Kitajima; Yoshikazu Kinoshita; Yusuke Demizu; Nobukazu Fuwa
Journal:  J Gastroenterol       Date:  2013-07-12       Impact factor: 7.527

3.  Effect of GutGard in the Management of Helicobacter pylori: A Randomized Double Blind Placebo Controlled Study.

Authors:  Sreenivasulu Puram; Hyung Chae Suh; Seung Un Kim; Bharathi Bethapudi; Joshua Allan Joseph; Amit Agarwal; Venkateswarlu Kudiganti
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-27       Impact factor: 2.629

4.  A possible role of IL-1RN gene polymorphism in the outcome of gastrointestinal diseases associated with H. pylori infection.

Authors:  Rejane Mattar; Sergio Barbosa Marques; Anibal Ferreira Dos Santos; Maria do Socorro Monteiro; Kiyoshi Iriya; Flair José Carrilho
Journal:  Clin Exp Gastroenterol       Date:  2013-04-18

5.  No association of coffee consumption with gastric ulcer, duodenal ulcer, reflux esophagitis, and non-erosive reflux disease: a cross-sectional study of 8,013 healthy subjects in Japan.

Authors:  Takeshi Shimamoto; Nobutake Yamamichi; Shinya Kodashima; Yu Takahashi; Mitsuhiro Fujishiro; Masashi Oka; Toru Mitsushima; Kazuhiko Koike
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

6.  Anti-Helicobacter pylori Properties of GutGard™.

Authors:  Jae Min Kim; Hong Mei Zheng; Boo Yong Lee; Woon Kyu Lee; Don Haeng Lee
Journal:  Prev Nutr Food Sci       Date:  2013-06

7.  Potential role of probiotics in the management of gastric ulcer.

Authors:  Ghalia Khoder; Asma A Al-Menhali; Farah Al-Yassir; Sherif M Karam
Journal:  Exp Ther Med       Date:  2016-04-26       Impact factor: 2.447

8.  Association of helicobacter pylori infection and chronic atrophic gastritis with risk of colonic, pancreatic and gastric cancer: A ten-year follow-up of the ESTHER cohort study.

Authors:  Xin-Zu Chen; Ben Schöttker; Felipe Andres Castro; Hongda Chen; Yan Zhang; Bernd Holleczek; Hermann Brenner
Journal:  Oncotarget       Date:  2016-03-29

9.  Assessment of Risk and Sero-Prevalence of Helicobacter pylori Colonization among Remote Orang Asli Tribes in Peninsula Malaysia.

Authors:  Kavitha Thevakumar; Josephine Rebecca Chandren; Guillermo Ignacio Perez-Perez; Eng Guan Chua; Lay Kek Teh; Mohd Zaki Salleh; Jin Ai Mary Anne Tan; Alex Hwong Ruey Leow; Khean Lee Goh; Alfred Chin Yen Tay; Barry J Marshall; Jamuna Vadivelu; Mun Fai Loke; Li Ping Wong
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

10.  In vitro and In vivo Anti-Helicobacter pylori Activities of Centella asiatica Leaf Extract.

Authors:  Hong-Mei Zheng; Myung-Joo Choi; Jae Min Kim; Kye Wan Lee; Yu Hwa Park; Don Haeng Lee
Journal:  Prev Nutr Food Sci       Date:  2016-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.